| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LogicMark, Inc. | President and CEO, Director | Common Stock | 153K | $69.8K | $0.46 | Aug 5, 2024 | Direct |
| Chromocell Therapeutics Corp | Director | Stock Option | 105K | Jun 14, 2024 | Direct | ||
| LogicMark, Inc. | President and CEO, Director | Series A Common Stock Purchase Warrant | 21.5K | Aug 5, 2024 | Direct | ||
| LogicMark, Inc. | President and CEO, Director | Series B Common Stock Purchase Warrant | 21.5K | Aug 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LGMK | LogicMark, Inc. | Aug 5, 2024 | 3 | $10K | 4 | Aug 6, 2024 | President and CEO, Director |
| CHRO | Chromocell Therapeutics Corp | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| LGMK | LogicMark, Inc. | Apr 3, 2024 | 1 | $0 | 4 | Apr 5, 2024 | President and CEO, Director |
| CHRO | Chromocell Therapeutics Corp | Feb 15, 2024 | 0 | $0 | 3 | Feb 15, 2024 | Director |
| LGMK | LogicMark, Inc. | Aug 7, 2023 | 1 | $0 | 4 | Aug 9, 2023 | Chief Executive Officer, Director |
| LGMK | Nxt-ID, Inc. | Jan 3, 2022 | 1 | $0 | 4/A | Feb 18, 2022 | Chief Executive Officer, Director |
| LGMK | Nxt-ID, Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Chief Executive Officer, Director |
| LGMK | Nxt-ID, Inc. | Jun 14, 2021 | 0 | $0 | 3 | Jun 23, 2021 | Chief Executive Officer, Director |